RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > FDA Looking for a Leader for its New Device Testing Division

FDA Looking for a Leader for its New Device Testing Division

Posted 04 November 2014 | By Alexander Gaffney, RAC

FDA Looking for a Leader for its New Device Testing Division

The US Food and Drug Administration (FDA) is on the hunt for a new leader for its device center's newly formed Division of Biology, Chemistry and Materials Science (DBCMS).

The new division, housed within the Center for Devices and Radiological Health's (CDRH) Office of Science and Engineering Laboratories (OSEL), is primarily concerned with how medical devices physically interact with patients. For example, its staff will be assessing devices for biocompatibility, biological risk assessment, toxicology, chemical contamination, electrochemistry, sterility, biofilm formation, materials degradation and more, FDA explained in a hiring notice posted on its website.

The data generated by DBCMS is used in both pre- and post-market settings, FDA noted.

FDA's ideal candidate for the director position will be an M.D. or Ph.D, have experience leading and managing a scientific organization and have a strong grasp of regulatory issues, the agency said.

 

Position Announcement

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.